HIGHLIGHTS
- who: Neuro-Oncology Advances and colleagues from the Aarhus University have published the paper: Neuro-Oncology Advances, in the Journal: (JOURNAL) of May/31,/2019
- what: The authors have evaluated the safety, feasibility, and preliminary efficacy of TTFields in combination with targeted SR-surgery against recurrent GBM.
- how: The study compared the efficacy of TTFields plus physician's choice chemotherapy with chemotherapy alone after the first recurrence.
- future: Collectively these studies indicate that part of the observations could possibly be explained by TTFields alone and further randomized studies are therefore needed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.